Shockwave Medical (SWAV) Stock Price, News & Analysis

Company Overview

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $334.75 to $334.75
• 50-Day Range: $328.87 to $334.83
• 52-Week Range: $157.00 to $334.90
• Volume: N/A
• Average Volume: 968,088 shs
• Market Capitalization: $12.57 billion
• P/E Ratio: 78.21
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SWAV Stock Analysis - Frequently Asked Questions

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) released its quarterly earnings data on Monday, May, 6th. The company reported $1.44 EPS for the quarter, beating analysts' consensus estimates of $0.99 by $0.45. The firm's quarterly revenue was up 35.8% on a year-over-year basis.

When did Shockwave Medical IPO?

Shockwave Medical (SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and CrowdStrike (CRWD).

Company Calendar

• Last Earnings: 5/06/2024
• Today: 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SWAV
• CIK: 1642545
• Web: www.shockwavemedical.com
• Phone: (877) 775-4846
• Fax: N/A
• Employees: 1,468
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $4.28
• Trailing P/E Ratio: 78.21
• Forward P/E Ratio: 66.29
• P/E Growth: 2.43
• Net Income: $147.28 million
• Net Margins: 20.75%
• Pretax Margin: 23.29%
• Return on Equity: 24.79%
• Return on Assets: 11.95%

Debt

• Debt-to-Equity Ratio: 0.97
• Current Ratio: 13.81
• Quick Ratio: 12.61

Sales & Book Value

• Annual Sales: $787.97 million
• Price / Sales: 15.95
• Cash Flow: $4.31 per share
• Price / Cash Flow: 77.61
• Book Value: $20.02 per share
• Price / Book: 16.72

Miscellaneous

• Outstanding Shares: 37,544,000
• Free Float: 36,268,000
• Market Cap: $12.57 billion
• Optionable: Optionable
• Beta: 0.88